INTRODUCTION
Antibodies directed toward intracellular targets are used in a large number of applications, the most common being protein localization studies (1) . Antibodies are also widely used to assess protein expression (2) , to block a protein function (3), or to confirm the efficiency of siRNA experiments by following a decrease in protein expression (2) . The antibodies used for specific detection can be either polyclonal or monoclonal and both types may be available with a tag (e.g., fluorescent-label, peroxidase-coupling). Due to their size and net charge, antibodies are unable to cross the plasma membrane by passive transport. Usually, the access of antibodies to intracellular targets is achieved by permeabilization of the cell membrane with detergents, consequently leading to cell damage. However, the ability to deliver functional antibodies to live cells presents such advantages as blocking a cellular pathway to study the physiological consequences, or following protein relocalization due to an exogenous stimulus. Physical methods have been used to introduce antibodies into mammalian live cells. Methods such as electroporation or microinjection that were first developed for gene transfection (4) were subsequently adapted for intracellular antibody delivery (3) . On the other hand, these methods require technical skills and present drawbacks; electroporation has a narrow window of efficiency and most often affects membrane integrity, while microinjection is limited to a few numbers of cells per experiment.
An alternative to these physical methods is to use a delivery reagent to allow the protein to cross the plasma membrane (5-7). The delivery reagent has (i) to form a noncovalent complex with the antibody to be delivered and (ii) to release the antibody in the cytoplasm in its native form to be functional. Indeed, the major obstacle for an effective delivery is the ability of the reagent to release antibodies intracellularly: only an efficient release will allow the antibody to reach its intracellular target and to interact tightly with it. As expected for an efficient protein delivery reagent, the fluorescent antibody delivered to live cells should label the cytoplasm in a pattern that is specific to the localization of its antigen. In this article, we present experimental data supporting efficient cationic lipid-mediated intracellular delivery of antibodies.
MATERIALS AND METHODS

Materials
Giantin polyclonal antibody and nuclear pore complex proteins monoclonal antibody, both AlexaFluor488-labeled, were obtained from Covance (Berkeley, CA, USA). Anti-mouse IgG, heavy and light chain (goat) fluorescein conjugate was purchased from Calbiochem (San Diego, CA, USA). ConcanavalinA, tetramethylrhodamine labeled, was obtained from Molecular Probes (Eugene, OR, USA). The 4′,6-diamidino-2-phenylindole (DAPI) was obtained from Sigma Chemical Co. (St. Louis, MO, USA). The antibody delivery reagent, PULSin, is a registered trademark of Polyplus-transfection (Illkirch, France).
Cell Culture
Human epithelial carcinoma cell line HeLa (ATCC CCL2) was cultured in Minimal Essential Medium (MEM, Eurobio, Courtaboeuf, France) at 37°C in 5% CO 2 . Culture media contained 10% heat-inactivated fetal bovine serum (FBS, Perbio, Brebières, France), penicillin (200 units/mL, Eurobio), streptomycin (200 μg/mL, Eurobio), and glutamine (2 mM, Eurobio).
Antibody Delivery Procedure
Cells (80,000/well) were seeded in a 24-well plate the day before the antibody delivery experiment in order to reach 70%-80% confluency when the antibody/ delivery reagent complexes were added to cells. For one well, 0.2-2 μL of antibody (see Materials section above) was diluted in 100 μL of 20 mM Hepes buffer (pH 7.4) in a microcentrifuge tube, under sterile conditions. Thereafter, 2.5 to 4 μL of delivery reagent were added to the antibody solution. Following homogenization, the antibody/ delivery reagent mix was incubated for 15 min at room temperature to allow complex formation. Cells were washed with 1 mL of PBS, and 900 μL of culture medium without serum were added. After addition of 100 μL antibody/reagent solution onto each well, the plate was gently mixed and further incubated at 37°C. Four hours later, the incubation medium was removed and replaced with fresh complete medium (containing serum). Antibody delivery was analyzed immediately or after additional incubation times.
Observation of Antibody Delivery
The observation of antibody delivery into cells was done by fluorescent micro- Short Technical Reports scopy (Nikon Eclipse TE2000-S fluorescent microscope coupled to a Nikon Coolpix 5400 camera; both from Nikon Instruments Europe, Badhoevedorp, The Netherlands). For cells observation, the incubation medium was removed and replaced by PBS. For cell membrane treatment with digitonine, the culture medium was removed and replaced by 1 mL of PBS. The digitonine solution was added to reach 10 μM in each well and pictures were taken at the indicated time. In order to prevent photobleaching of the fluorophores, the shutter was used between two pictures to cut off the fluorescent beam. At the end of the experiment, DAPI and ConcanavalinArhodamine solutions were added to a final concentration of 0.5 μM and 12 μg/mL, respectively, and incubated for 10 min before taking pictures.
Immunocytochemistry
HeLa cells were grown for one day on a LabTek Chamber Slide system (Nunc, Roskilde, Denmark). Cells were briefly rinsed twice with PBS, fixed, and permeabilized with cold methanol/acetone (1/1 solution) for 10 min at 4°C. Cells were washed twice with PBS and further incubated for 20 min at 4°C with PBS supplemented with 1% BSA. Blocking buffer was replaced by nuclear pore complex proteins monoclonal antibody (anti-NPC-AF488 antibody; 1:5000 dilution in PBS-1% BSA buffer). The LabTek slide was further incubated for 30 min at 4°C. After two washes with PBS, DAPI and ConcanavalinA-rhodamine solutions were added to a final concentration of 0.5 μM and 12 μg/mL, respectively, and incubated for 10 min at 4°C. Cells were further incubated in PBS and observed by fluorescent microscopy.
RESULTS AND DISCUSSION
Antibody Delivery to Cytoplasm via Cationic Lipid−based Reagent
Antibodies are ∼150 kDa-large proteins and hence unable to cross the plasma membrane. As shown in Figure 1A , the addition of a fluorescent primary antibody directed against giantin, a transmembrane Golgi protein, to live HeLa cells did not show any intracellular labeling fluorescent signal. Therefore, a cell membrane permeabilization procedure is required, or a delivery reagent for antibodies to reach intracellular antigens can be used. For example, when the same anti-giantin antibody was first incubated with a protein delivery reagent to allow complex formation prior to incubation with live cells, intracellular fluorescence was observed in all cells with the expected pattern; that is, labeling of a cytoplasmic region near the nuclear compartment ( Figure 1B) . This fluorescent pattern obtained in live cells was identical to that expected for Golgi apparatus labeling (2) without affecting membrane integrity. The nuclear stain DAPI, when used at low concentration, is unable to cross the plasma membrane of living cells (8) . In contrast, when used on fixed cells, DAPI stains cell nuclei. The absence of nuclear blue DAPI labeling in live cells shown in Figure 1A and 1B confirms the integrity of the cellular membrane after antibody delivery.
As a result, the protein delivery reagent successfully delivers functional antibodies to live cells without affecting cell membrane integrity. This delivery reagent is a formulation of cationic lipids (dioctadecylamidoglycylspermine) able to form noncovalent complexes with anionic proteins, such as antibodies, via both electrostatic and hydrophobic interactions. We assume that the protein delivery mechanism using such cationic lipids is similar to that of gene delivery. Protein/delivery reagent noncovalent complexes interact with the cell surface by binding to heparan sulfate proteoglycans (9,10) and are subsequently internalized by endocytosis. The cationic amphiphilic-based reagent then induces the endosomes' escape followed by the complexes' disassembly.
Pattern of Cellular Labeling
In order to check the validity of antibody delivery into live cells with a carrier, we compared the labeling with that obtained by immunocytochemistry in fixed cells using the same monoclonal primary antibody (Figure 2 ). We used an AlexaFluor488 antinuclear pore complex proteins antibody to label the nuclear membrane of HeLa cells. Just before observation, the cell membrane was labeled with ConcanavalinA-rhodamine (ConA) and the nuclear compartment stained with DAPI to determine the cell membrane integrity. The analysis by fluorescent microscopy of the immunocytochemistry experiment (Figure 2A) shows a homogeneous green fluorescent signal surrounding the nuclear compartment. Due to cell membrane permeabilization, ConA labels the network of intracellular compartments and DAPI shows an intense staining of the nuclear compartment. When the Short Technical Reports fluorescent antibody was delivered to live cells using a delivery reagent ( Figure 2B ), we observed that most of the fluorescent signal was located near the nuclear membrane. Nuclear DAPI staining was observed for fixed cells as well as for live cells following digitonine treatment ( Figure  2 , A and C). In contrast, the absence of nuclear DAPI staining in live cells ( Figure  2B ) confirmed the integrity of the cellular membrane after antibody delivery. When compared with immunocytochemistry experiments (Figure 2A) , the pattern of antibody labeling with a delivery reagent on live cells ( Figure 2B ) is comparable, showing in both cases labeling of the perinuclear space. The major difference remains the status of cells: live cells in antibody delivery experiments, as shown by the absence of nuclear staining and the ConA labeling, restricted to the cell membrane, compared to fixed and permeabilized cells in the immunocytochemistry approach. Thus, the use of a delivery reagent for antibodies allows dynamic and kinetic studies to be performed.
Results shown in Figures 1 and 2 together confirm that the delivery reagent allows antibodies to cross the plasma membrane without affecting cell membrane integrity as well as efficient intracellular release of the antibodies into the cytoplasm where they diffuse to their target.
Delivery of Antibodies in Live Cells
Three fluorescently labeled antibodies (anti-mouse IgG, anti-giantin, and anti-NPC) were delivered into live cells using a protein delivery reagent. The anti-mouse IgG (a secondary antibody) is devoid of an intracellular target. As shown in Figure  3A (t = 0), anti-mouse IgG filled the cytoplasm, without any specific pattern. This labeling pattern contrasts with that of primary antibodies; for example, an antigiantin polyclonal antibody ( Figure 3B ) is specifically localized near the nuclear compartment of live cells, as expected for Golgi apparatus localization. A ring pattern corresponding to nuclear membrane staining is observed when delivering an antibody directed against nuclear pore complex proteins ( Figure 3C ). In addition, as shown in Figure 3 (left column), the delivery reagent allows efficient release of antibodies into the cytoplasm, and subsequent specific interaction with their intracellular target.
Following antibody delivery, we used digitonine to permeabilize the plasma membrane and study the evolution of the fluorescent antibodies. Digitonine is a soft detergent selectively permeabilizing the plasma membrane and inducing diffusion of soluble molecules present in the cells to the extracellular medium (11). We followed the behavior of delivered antibodies as a function of time in the presence of digitonine (Figure 3) . The nonspecific antimouse IgG secondary antibody ( Figure 3A) quickly escapes from the cytoplasm while primary antibodies (Figure 3 , B and C) remain within the cytoplasm even after 15 min of digitonine treatment.
This experiment suggests that primary antibodies interact tightly with their antigens. We confirmed the permeabilization of the plasma membrane of the HeLa cells by DAPI labeling (data not shown). Furthermore, we checked to determine if the decrease in fluorescence was not due to photobleaching. For this purpose, cells incubated in PBS without digitonine were illuminated in the same conditions and observed for 15 min. No significant decrease 
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of the fluorescent signal was observed in these conditions (data not shown). Thus, we confirmed that the fluorescent signal decrease observed upon digitonine addition is not due to photobleaching but to the escape of the antibody when using an antibody devoid of cytoplasmic target.
Cause of Variation in Specificity of Signal
For immunocytochemistry experiments, the cells are permeabilized. Extensive washing steps eliminate unbound antibodies thus avoiding nonspecific signals. In live cells, the amount of fluorescent antibody bound in the complexes with the delivery reagent is fully delivered to the cytoplasm. Therefore, upon saturation of the antigen by the antibody, the remaining fraction of antibody is likely to induce a nonspecific signal in the cytoplasm. As shown in Figure  4 , increasing the volume of anti-giantin-AF488 antibody delivered into HeLa cells lowered the signal-to-noise ratio. The lower volume of antibody tested (0.5 μL) led to a homogenous fluorescent signal into HeLa cells ( Figure 4A ). In each cell, a cytoplasmic region localized near the nuclear compartment was clearly labeled. When using a higher amount of anti-giantin antibody (1 and 2 μL), the antigen was saturated and a nonspecific intracellular fluorescent signal (white arrows) appeared, due to free antibodies ( Figure 4 , B and C, respectively). As for immunocytochemistry experiments, this result highlights the importance of optimizing the antibody titer to enhance the signal-to-noise ratio and obtain significant data.
Conclusion
In this report, we have presented a detailed study supporting the potential of antibody delivery into live cells. The labeling patterns obtained are in keeping with those observed using an immunocytochemistry approach. We have provided evidence for an effective release of antibody in the cytoplasm when introduced into cells without deleterious effect on the integrity of the plasma membrane. We have demonstrated that the determination of optimal conditions is required for efficient delivery, especially regarding the amount of antibody. Recent data support the potency of this delivery method to introduce functional antibodies to live cells (12, 13) . Indeed, Cassinelli and colleagues (12) delivered an anti-phosphorylated Met antibody into a human lung cancer cell line (H460). The intracellular delivery of this antibody induced a significant inhibition of cell migration and invasiveness. Neither the delivered control IgG nor the delivery reagent alone was able to induce any effect. An anti-importin-β1 antibody was delivered into primary mouse Sertoli cells by Ying and collaborators (13) . This blocking antibody induced a drastic inhibition of the nuclear import of a transcription factor (DRMT1), while a nonspecific IgG did not affect the nuclear localization of this transcription factor. Altogether these data confirm the potency of the delivery method based on cationic lipid reagent as well as the potential interest for biological and functional applications after intracellular delivery of antibodies into live cells.
